---
figid: PMC6237574__JCMM-22-6368-g008
figtitle: Metformin/AMPK/ER signalling crosstalk with bromocriptine/D2R pathway in
  prolactinoma treatment
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC6237574
filename: JCMM-22-6368-g008.jpg
figlink: /pmc/articles/PMC6237574/figure/jcmm13963-fig-0008/
number: F8
caption: Schematic representation of metformin/AMPK/ER signalling pathway and its
  potential crosstalk with bromocriptine/D2R pathway in prolactinoma treatment. Red
  arrow/line refers to regulatory relationship proposed in this study. Dashed line
  with question mark refers to potential AMPK‐independent pathway for BC/D2R to regulate
  ER expression
papertitle: Metformin inhibits growth and prolactin secretion of pituitary prolactinoma
  cells and xenografts.
reftext: Jun Gao, et al. J Cell Mol Med. 2018 Dec;22(12):6368-6379.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9688435
figid_alias: PMC6237574__F8
figtype: Figure
redirect_from: /figures/PMC6237574__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6237574__JCMM-22-6368-g008.html
  '@type': Dataset
  description: Schematic representation of metformin/AMPK/ER signalling pathway and
    its potential crosstalk with bromocriptine/D2R pathway in prolactinoma treatment.
    Red arrow/line refers to regulatory relationship proposed in this study. Dashed
    line with question mark refers to potential AMPK‐independent pathway for BC/D2R
    to regulate ER expression
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - DRD2
  - ESR1
  - ERAL1
  - Prolactinoma
---
